1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide

C73H67N5Pt — CID 177105685

IUPAC1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide
SMILES[2H]c1cc(N2[CH-]N(c3c(-c4ccccc4)c([2H])c([2H])c([2H])c3-c3ccc4c(c3)C(C)(C)CCC4(C)C)c3ccccc32)[c-]c(N2[CH-]N(c3c(-c4ccccc4)c([2H])c([2H])c([2H])c3-c3ccc4c(c3)C(C)(C)CCC4(C)C)c3ccccc32)c1.[C-]#N.[Pt+4]
InChIInChI=1S/C72H67N4.CN.Pt/c1-69(2)40-42-71(5,6)61-44-51(36-38-59(61)69)57-30-20-28-55(49-22-11-9-12-23-49)67(57)75-47-73(63-32-15-17-34-65(63)75)53-26-19-27-54(46-53)74-48-76(66-35-18-16-33-64(66)74)68-56(50-24-13-10-14-25-50)29-21-31-58(68)52-37-39-60-62(45-52)72(7,8)43-41-70(60,3)4;1-2;/h9-39,44-45,47-48H,40-43H2,1-8H3;;/q-3;-1;+4/i19D,20D,21D,28D,29D,30D,31D;;
InChIKeyPRULQLOEMARGAL-ZIQRTKTBSA-N
MW1216.49 g/mol
LogP19.76
Rot. Bonds8

About 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide

1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide (PubChem CID 177105685) has the molecular formula C73H67N5Pt and a molecular weight of 1216.49 g/mol. Its IUPAC name is 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide.

Molecular Properties

Compound Name1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide
PubChem CID177105685
Molecular FormulaC73H67N5Pt
Molecular Weight1216.49 g/mol
Exact Mass1215.55
IUPAC Name1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide
SMILES[2H]c1cc(N2[CH-]N(c3c(-c4ccccc4)c([2H])c([2H])c([2H])c3-c3ccc4c(c3)C(C)(C)CCC4(C)C)c3ccccc32)[c-]c(N2[CH-]N(c3c(-c4ccccc4)c([2H])c([2H])c([2H])c3-c3ccc4c(c3)C(C)(C)CCC4(C)C)c3ccccc32)c1.[C-]#N.[Pt+4]
InChIInChI=1S/C72H67N4.CN.Pt/c1-69(2)40-42-71(5,6)61-44-51(36-38-59(61)69)57-30-20-28-55(49-22-11-9-12-23-49)67(57)75-47-73(63-32-15-17-34-65(63)75)53-26-19-27-54(46-53)74-48-76(66-35-18-16-33-64(66)74)68-56(50-24-13-10-14-25-50)29-21-31-58(68)52-37-39-60-62(45-52)72(7,8)43-41-70(60,3)4;1-2;/h9-39,44-45,47-48H,40-43H2,1-8H3;;/q-3;-1;+4/i19D,20D,21D,28D,29D,30D,31D;;
InChIKeyPRULQLOEMARGAL-ZIQRTKTBSA-N
XLogP19.76
TPSA36.75 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds8
Heavy Atoms79
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001216.49
LogP ≤ 519.76
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide?
The IUPAC name of 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide (CID 177105685) is 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide.
What is the SMILES notation for 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide?
The canonical SMILES for 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide is [2H]c1cc(N2[CH-]N(c3c(-c4ccccc4)c([2H])c([2H])c([2H])c3-c3ccc4c(c3)C(C)(C)CCC4(C)C)c3ccccc32)[c-]c(N2[CH-]N(c3c(-c4ccccc4)c([2H])c([2H])c([2H])c3-c3ccc4c(c3)C(C)(C)CCC4(C)C)c3ccccc32)c1.[C-]#N.[Pt+4].
What is the InChIKey of 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide?
The InChIKey is PRULQLOEMARGAL-ZIQRTKTBSA-N. The full InChI is InChI=1S/C72H67N4.CN.Pt/c1-69(2)40-42-71(5,6)61-44-51(36-38-59(61)69)57-30-20-28-55(49-22-11-9-12-23-49)67(57)75-47-73(63-32-15-17-34-65(63)75)53-26-19-27-54(46-53)74-48-76(66-35-18-16-33-64(66)74)68-56(50-24-13-10-14-25-50)29-21-31-58(68)52-37-39-60-62(45-52)72(7,8)43-41-70(60,3)4;1-2;/h9-39,44-45,47-48H,40-43H2,1-8H3;;/q-3;-1;+4/i19D,20D,21D,28D,29D,30D,31D;;.
What are the key properties of 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide?
1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide has a molecular weight of 1216.49 g/mol, XLogP of 19.76, 8 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[3-deuterio-5-[3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-6-id-1-yl]-3-[3,4,5-trideuterio-2-phenyl-6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-ide;platinum(4+);cyanide is sourced from PubChem (CID 177105685), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).